TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 17137759

Group type: EXPERIMENTAL
Intervention: Clozapine
Number of subjects: 7728

Group type: EXPERIMENTAL
Intervention: Olanzapine
Number of subjects: 7728

Group type: EXPERIMENTAL
Intervention: Quetiapine
Number of subjects: 7728

Group type: COMPARATOR
Intervention: Risperidone
Number of subjects: 7728

Group type: COMPARATOR
Intervention: Amisulpride
Number of subjects: 7728

Group type: COMPARATOR
Intervention: Typical antipsychotics (oral and depot)
Number of subjects: 7728
Study: 15818610

Group type: EXPERIMENTAL
Intervention: Visual inspection with acetic acid (VIA)
Number of subjects: 142701

Group type: EXPERIMENTAL
Intervention: Cytology
Number of subjects: 142701

Group type: EXPERIMENTAL
Intervention: HPV testing
Number of subjects: 142701

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 142701
Study: 11939808

Group type: EXPERIMENTAL
Intervention: Interferon alfa‐2a, 6 x 10(6) IU, subcutaneously 3 times per week for 3 months
Number of subjects: 50

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50
Study: 10219009

Group type: EXPERIMENTAL
Intervention: High-intensity cycling (70% heart rate reserve)
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Low-intensity cycling (40% heart rate reserve)
Number of subjects: 39

Group type: COMPARATOR
Intervention: Both high-intensity and low-intensity cycling
Number of subjects: 39
Study: 10155353

Group type: EXPERIMENTAL
Intervention: Autohaler (AH) early canister life
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Autohaler (AH) late canister life
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Autohaler (AH)
Number of subjects: 12
Study: 2368243

Group type: EXPERIMENTAL
Intervention: He‐Ne laser therapy
Number of subjects: 48

Group type: COMPARATOR
Intervention: Placebo (slit lamp with blinking light)
Number of subjects: 48

Group type: COMPARATOR
Intervention: No treatment (absolute controls)
Number of subjects: 48
Study: 519269

Group type: EXPERIMENTAL
Intervention: Education and tailoring programme for compliance improvement
Number of subjects: 82

Group type: COMPARATOR
Intervention: Standard treatment with medication monitor
Number of subjects: 82
Study: 31418925

Group type: EXPERIMENTAL
Intervention: Biophilic design in VR
Number of subjects: 30

Group type: COMPARATOR
Intervention: Base case (no biophilic elements)
Number of subjects: 30
Study: 29173199

Group type: EXPERIMENTAL
Intervention: n-3 fatty acids (3.7 g daily)
Number of subjects: 98

Group type: COMPARATOR
Intervention: Control (olive oil)
Number of subjects: 98
Study: 26209000

Group type: EXPERIMENTAL
Intervention: LCZ696 (dual‐acting angiotensin receptor blocker and neprilysin inhibitor)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Enalapril (ACE inhibitor)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: LCZ696
Number of subjects: 0
Study: 24635770

Group type: EXPERIMENTAL
Intervention: High-target group (80 to 85 mm Hg)
Number of subjects: 776

Group type: COMPARATOR
Intervention: Low-target group (65 to 70 mm Hg)
Number of subjects: 776

Group type: EXPERIMENTAL
Intervention: High-target group (80 to 85 mm Hg) among patients with chronic hypertension
Number of subjects: 776
Study: 22562179

Group type: EXPERIMENTAL
Intervention: Low-Carbohydrate Diet (LCD)
Number of subjects: 61

Group type: COMPARATOR
Intervention: Low-Fat Diet (LFD)
Number of subjects: 61
Study: 19286153

Group type: EXPERIMENTAL
Intervention: AcrySof Toric IOL implantation
Number of subjects: 32
Study: 17880335

Group type: EXPERIMENTAL
Intervention: Tecnic Carbostent (T)
Number of subjects: 63

Group type: COMPARATOR
Intervention: Rx Multi-Link Penta (P)
Number of subjects: 63
Study: 15574547

Group type: EXPERIMENTAL
Intervention: Gabapentin 300 mg
Number of subjects: 56

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 56
Study: 12074617

Group type: EXPERIMENTAL
Intervention: Steroid (Depo‐Medrone) injection preoperatively
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Cultured Dupuytren's cells
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control fibroblasts from palmar fascia and fascia lata
Number of subjects: 0
Study: 9591619

Group type: EXPERIMENTAL
Intervention: Simulated combat flight
Number of subjects: 10

Group type: COMPARATOR
Intervention: Control period (ground duties)
Number of subjects: 10
Study: 8175411

Group type: EXPERIMENTAL
Intervention: Radiotherapy for left sided breast cancer (either tangential field 60Co or electron-therapy)
Number of subjects: 37

Group type: COMPARATOR
Intervention: Control group (either treated for right sided disease or nonirradiated)
Number of subjects: 37
Study: 2681103

Group type: EXPERIMENTAL
Intervention: Mixed beam radiation therapy
Number of subjects: 327

Group type: COMPARATOR
Intervention: Photon radiation therapy
Number of subjects: 327
Study: 6988336

Group type: EXPERIMENTAL
Intervention: Valgus osteotomy using a neck‐shaft angle of at least 140 degrees
Number of subjects: 62

Group type: COMPARATOR
Intervention: Nail plating with 130 degrees neck‐shaft angle
Number of subjects: 62
Study: 30482511

Group type: EXPERIMENTAL
Intervention: First trimester tear osmolarity measurement (304.9 ± 8.0 mOsm/L)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Last trimester tear osmolarity measurement (300.2 ± 7.1 mOsm/L)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: First trimester Schirmer test results (18.1 ± 6.3 mm)
Number of subjects: 60
Study: 28112433

Group type: EXPERIMENTAL
Intervention: Usual care (medication management)
Number of subjects: 132

Group type: EXPERIMENTAL
Intervention: Usual care (psychotherapy)
Number of subjects: 132

Group type: EXPERIMENTAL
Intervention: Usual care (evidence-based psychotherapy)
Number of subjects: 132

Group type: EXPERIMENTAL
Intervention: Usual care (group psychotherapy)
Number of subjects: 132

Group type: EXPERIMENTAL
Intervention: Usual care (interactive video psychotherapy)
Number of subjects: 132
Study: 25847775

Group type: EXPERIMENTAL
Intervention: Huanshuai Recipe Oral Liquid (HSR), 20 mL, 3 times a day for 6 months
Number of subjects: 52

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 52
Study: 23666972

Group type: EXPERIMENTAL
Intervention: Biliopancreatic diversion (BPD)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: BPD
Number of subjects: 15
Study: 21392111

Group type: EXPERIMENTAL
Intervention: Talaporfin sodium (0.25-1.0 mg/kg)
Number of subjects: 20
Study: 19413507

Group type: EXPERIMENTAL
Intervention: Four‐Agents‐Decoction (Si Wu Tang)
Number of subjects: 76

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 76
Study: 18490847

Group type: EXPERIMENTAL
Intervention: Pre-germinated brown rice (PGBR) diet (3 packs of cooked PGBR, 180 g/pack daily for 6 weeks)
Number of subjects: 11

Group type: COMPARATOR
Intervention: White rice (WR) diet (3 packs of cooked WR, 180 g/pack daily for 6 weeks)
Number of subjects: 11
Study: 15350711

Group type: EXPERIMENTAL
Intervention: 80% ethanol with 0.5% chlorhexidine (CHD group)
Number of subjects: 100

Group type: COMPARATOR
Intervention: 80% ethanol alone (EtOH group)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Both groups (CHD and EtOH)
Number of subjects: 100
Study: 11506111

Group type: EXPERIMENTAL
Intervention: 5 mg morphine infiltrated into the harvest site
Number of subjects: 60

Group type: COMPARATOR
Intervention: 5 mg intramuscular morphine
Number of subjects: 60

Group type: COMPARATOR
Intervention: Saline infiltrated into the harvest site
Number of subjects: 60
Study: 9427017

Group type: EXPERIMENTAL
Intervention: Radiotherapy combined with resection surgery
Number of subjects: 150

Group type: COMPARATOR
Intervention: Surgery alone
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Adjuvant radiotherapy (including IORT) with resection surgery
Number of subjects: 150
Study: 8321112

Group type: EXPERIMENTAL
Intervention: L-carnitine (CARN) 3 g.d-1 for 7 d
Number of subjects: 9

Group type: COMPARATOR
Intervention: Placebo (CONT)
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: L-carnitine (CARN)
Number of subjects: 9
Study: 3790647

Group type: EXPERIMENTAL
Intervention: 4 mg Pindolol
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: 1.5 mg Cloxazolam
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: 4 mg Pindolol + 1.5 mg Cloxazolam
Number of subjects: 48

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 48
Study: 11573527

Group type: EXPERIMENTAL
Intervention: Phenylephrine 4 mg i.m.
Number of subjects: 108

Group type: COMPARATOR
Intervention: Phenylephrine 2 mg i.m.
Number of subjects: 108

Group type: EXPERIMENTAL
Intervention: Ephedrine 45 mg i.m.
Number of subjects: 108

Group type: COMPARATOR
Intervention: Control (saline i.m.)
Number of subjects: 108
Study: 29605459

Group type: EXPERIMENTAL
Intervention: ilioinguinal-iliohypogastric nerve block
Number of subjects: 50

Group type: COMPARATOR
Intervention: medial transverse abdominis plane block
Number of subjects: 50
Study: 29298938

Group type: EXPERIMENTAL
Intervention: Facial photos taken 2 h after injection with 2.0 ng kg‐1 lipopolysaccharide (bacterial stimulus)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Facial photos taken 2 h after injection with placebo
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Facial cues observed in acutely sick individuals
Number of subjects: 0
Study: 27354761

Group type: EXPERIMENTAL
Intervention: Mometasone furoate intranasal steroid
Number of subjects: 100

Group type: COMPARATOR
Intervention: Fluticasone furoate intranasal steroid
Number of subjects: 100
Study: 25387037

Group type: EXPERIMENTAL
Intervention: Construction task performance methodology
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: Construction play performance
Number of subjects: 96
Study: 21952693

Group type: EXPERIMENTAL
Intervention: Soy protein supplementation (40g/day for 8 weeks)
Number of subjects: 352

Group type: COMPARATOR
Intervention: Milk protein supplementation (40g/day for 8 weeks)
Number of subjects: 352
Study: 19785605

Group type: EXPERIMENTAL
Intervention: Topical miltefosine and clobetasol
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Clobetasol
Number of subjects: 39

Group type: COMPARATOR
Intervention: Topical miltefosine
Number of subjects: 39
Study: 17431777

Group type: EXPERIMENTAL
Intervention: Adefovir 10 mg/day (Group 1)
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: Adefovir 10 mg/day and lamivudine 100 mg once daily (Group 2)
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: Adefovir alone
Number of subjects: 54
Study: 16280250

Group type: EXPERIMENTAL
Intervention: Levetiracetam (1,000-4,000 mg/day)
Number of subjects: 280

Group type: EXPERIMENTAL
Intervention: Levetiracetam monotherapy
Number of subjects: 280

Group type: EXPERIMENTAL
Intervention: Levetiracetam
Number of subjects: 280
Study: 12358344

Group type: EXPERIMENTAL
Intervention: Tobramycin nebuliser solution (TNS)
Number of subjects: 115

Group type: COMPARATOR
Intervention: Colistin
Number of subjects: 115
Study: 9949318

Group type: EXPERIMENTAL
Intervention: Fluticasone propionate 500 microg twice daily
Number of subjects: 111

Group type: EXPERIMENTAL
Intervention: Fluticasone propionate 1000 microg twice daily
Number of subjects: 111

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 111

Group type: EXPERIMENTAL
Intervention: Fluticasone propionate
Number of subjects: 111
Study: 7776474

Group type: EXPERIMENTAL
Intervention: CT measurements of AAA diameter (local and central)
Number of subjects: 806

Group type: EXPERIMENTAL
Intervention: Central CT remeasurements
Number of subjects: 806

Group type: COMPARATOR
Intervention: Ultrasound measurements compared to central CT measurements
Number of subjects: 806
Study: 2262582

Group type: EXPERIMENTAL
Intervention: Triclosan containing oral hygiene products
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Stannous fluoride containing oral hygiene products
Number of subjects: 16

Group type: COMPARATOR
Intervention: Chlorhexidine rinse
Number of subjects: 16

Group type: COMPARATOR
Intervention: Saline
Number of subjects: 16
Study: 441879

Group type: EXPERIMENTAL
Intervention: Intravenous iron therapy
Number of subjects: 55

Group type: COMPARATOR
Intervention: Oral iron therapy
Number of subjects: 55
Study: 31192643

Group type: EXPERIMENTAL
Intervention: Parents who received additional guidance to focus on teaching numbers during tablet play.
Number of subjects: 51

Group type: COMPARATOR
Intervention: Parents who did not receive additional guidance to focus on teaching numbers during tablet play.
Number of subjects: 51
Study: 28476871

Group type: EXPERIMENTAL
Intervention: Liraglutide
Number of subjects: 9340

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 9340
Study: 26367529

Group type: EXPERIMENTAL
Intervention: High protein diet (2.4 g protein/kg/d)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Low protein diet (0.4 g protein/kg/d)
Number of subjects: 40
Study: 23615479

Group type: EXPERIMENTAL
Intervention: IV + OR
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: IV and IV + OR
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: IV + OR [AVP]
Number of subjects: 12
Study: 22518934

Group type: EXPERIMENTAL
Intervention: Vitamin C treatment group (1000 mg d(‐1))
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo group
Number of subjects: 30
Study: 19158129

Group type: EXPERIMENTAL
Intervention: Aerobic exercise at 50% VO(2max) for 60 min
Number of subjects: 14

Group type: COMPARATOR
Intervention: Rest for 60 min
Number of subjects: 14
Study: 17410435

Group type: EXPERIMENTAL
Intervention: mesalazine, 800 mg bid
Number of subjects: 268

Group type: EXPERIMENTAL
Intervention: mesalazine, 400 mg bid
Number of subjects: 268

Group type: COMPARATOR
Intervention: rifaximin, 200 mg bid
Number of subjects: 268

Group type: COMPARATOR
Intervention: rifaximin, 400 mg bid
Number of subjects: 268
Study: 15628774

Group type: EXPERIMENTAL
Intervention: Deep needling to trigger points
Number of subjects: 35

Group type: COMPARATOR
Intervention: Standard acupuncture
Number of subjects: 35

Group type: COMPARATOR
Intervention: Superficial needling to trigger points
Number of subjects: 35
Study: 11529449

Group type: EXPERIMENTAL
Intervention: Brief, transitional acute care emphasizing home-based counseling and support, 24-hour rapid response, rural outreach, and intensive support management.
Number of subjects: 182

Group type: COMPARATOR
Intervention: Routine care control group.
Number of subjects: 182
Study: 9397285

Group type: COMPARATOR
Intervention: Placebo condition (irrelevant decision balance sheet)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Experimental condition (relevant decision balance sheet)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control condition (no intervention)
Number of subjects: 0
Study: 7955976

Group type: COMPARATOR
Intervention: Self-report compliance
Number of subjects: 424

Group type: COMPARATOR
Intervention: Personality and intelligence variables
Number of subjects: 424

Group type: COMPARATOR
Intervention: Age and duration of diabetes
Number of subjects: 424

Group type: COMPARATOR
Intervention: Onset-age of diabetes
Number of subjects: 424

Group type: COMPARATOR
Intervention: Personality variables
Number of subjects: 424
Study: 3593994

Group type: EXPERIMENTAL
Intervention: Domperidone (0.1 mg X kg‐1 i.v.)
Number of subjects: 11

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 11
Study: 30297759

Group type: EXPERIMENTAL
Intervention: Oats soaked overnight in skim milk (ONO)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Oats soaked overnight in skim milk with sugar, nuts, and seeds (ONOsns)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Cooked cream of rice cereal (CR)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Cooked cream of rice cereal with sugar, nuts, and seeds (CRsns)
Number of subjects: 80
Study: 28575891

Group type: EXPERIMENTAL
Intervention: Automated chest compressions
Number of subjects: 12

Group type: COMPARATOR
Intervention: Manual chest compressions
Number of subjects: 12
Study: 26081100

Group type: EXPERIMENTAL
Intervention: 100 mg CoQ10 twice daily for 1 week
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 23605473

Group type: EXPERIMENTAL
Intervention: Assets‐Getting To Outcomes (AGTO) intervention
Number of subjects: 32

Group type: COMPARATOR
Intervention: Control group (non-users of AGTO)
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: AGTO intervention programs
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: AGTO intervention
Number of subjects: 32
Study: 21270793

Group type: EXPERIMENTAL
Intervention: Rifampin
Number of subjects: 16
Study: 19465123

Group type: EXPERIMENTAL
Intervention: Celecoxib 200mg capsules in the fed state
Number of subjects: 0

Group type: COMPARATOR
Intervention: Celecoxib 200mg capsules in the fasted state
Number of subjects: 0
Study: 17072271

Group type: EXPERIMENTAL
Intervention: Accelerated vaccination program (day 0, 10, 21)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Classical vaccination program (day 0, 30, 60)
Number of subjects: 0
Study: 15063888

Group type: EXPERIMENTAL
Intervention: Group 1 (nurse called participants)
Number of subjects: 469

Group type: COMPARATOR
Intervention: Group 2 (participants called themselves)
Number of subjects: 469

Group type: EXPERIMENTAL
Intervention: Flexible sigmoidoscopy procedure
Number of subjects: 469

Group type: EXPERIMENTAL
Intervention: Overall experience of flexible sigmoidoscopy
Number of subjects: 469

Group type: EXPERIMENTAL
Intervention: Failures in examination
Number of subjects: 469
Study: 10776222

Group type: EXPERIMENTAL
Intervention: Foam mattress (TheraRest)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Water mattress (Secutex)
Number of subjects: 120
Study: 8676529

Group type: EXPERIMENTAL
Intervention: Abrupt discontinuation of TPN
Number of subjects: 21

Group type: COMPARATOR
Intervention: Tapering of TPN (decreasing infusion rate by 50% for 1 hour before discontinuation)
Number of subjects: 21
Study: 1373535

Group type: EXPERIMENTAL
Intervention: Cyclosporine A (CsA)
Number of subjects: 140

Group type: EXPERIMENTAL
Intervention: FK506 (FK)
Number of subjects: 140

Group type: EXPERIMENTAL
Intervention: Cyclosporine A (CsA) with OKT3
Number of subjects: 140

Group type: EXPERIMENTAL
Intervention: FK506 (FK) with OKT3
Number of subjects: 140
Study: 6475824

Group type: EXPERIMENTAL
Intervention: Inorganic iron, 920 mumol (51 mg)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: HB iron, 480 mumol (26 mg)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Inorganic iron, 610 mumol (34 mg)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Tin, 306 mumol (36 mg)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Copper, 79 mumol (5 mg)
Number of subjects: 0
Study: 31106336

Group type: EXPERIMENTAL
Intervention: Cardiac resynchronization therapy (CRT) defibrillating device
Number of subjects: 0

Group type: COMPARATOR
Intervention: Cardiac resynchronization therapy (CRT) pacer
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: CRT in patients with wide QRS (>150 ms)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: CRT in patients with narrow QRS (<130 ms)
Number of subjects: 0
Study: 28573672

Group type: EXPERIMENTAL
Intervention: MEMO CBT
Number of subjects: 855

Group type: COMPARATOR
Intervention: MEMO Control
Number of subjects: 855
Study: 25909608

Group type: EXPERIMENTAL
Intervention: Analgin
Number of subjects: 112

Group type: EXPERIMENTAL
Intervention: Dexalgin
Number of subjects: 112

Group type: EXPERIMENTAL
Intervention: Paracetamol
Number of subjects: 112

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 112
Study: 23677249

Group type: EXPERIMENTAL
Intervention: Desmopressin melt (120/240 μg)
Number of subjects: 221

Group type: COMPARATOR
Intervention: Desmopressin tablet (0.2/0.4 mg)
Number of subjects: 221
Study: 21843943

Group type: EXPERIMENTAL
Intervention: Weekly nab-paclitaxel (150 mg/m2)
Number of subjects: 114

Group type: COMPARATOR
Intervention: q3w nab-paclitaxel
Number of subjects: 114

Group type: COMPARATOR
Intervention: Docetaxel
Number of subjects: 114

Group type: COMPARATOR
Intervention: Solvent-based paclitaxel
Number of subjects: 114
Study: 19631353

Group type: EXPERIMENTAL
Intervention: High-glycemic index/glycemic load diet
Number of subjects: 24

Group type: COMPARATOR
Intervention: Low-glycemic index/glycemic load diet
Number of subjects: 24
Study: 17277647

Group type: EXPERIMENTAL
Intervention: Mild water-filtered near infrared whole-body hyperthermia (NI-WBH) plus multimodal rehabilitation (MR)
Number of subjects: 139

Group type: COMPARATOR
Intervention: Multimodal rehabilitation (MR) only
Number of subjects: 139

Group type: EXPERIMENTAL
Intervention: NI-WBH plus MR
Number of subjects: 139

Group type: COMPARATOR
Intervention: MR only
Number of subjects: 139
Study: 15142029

Group type: EXPERIMENTAL
Intervention: Mg(2+)-Cr group (2.5 g of Cr daily)
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: Cr group (2.5 g of Cr daily)
Number of subjects: 31

Group type: COMPARATOR
Intervention: Placebo group (multidextran)
Number of subjects: 31
Study: 12074415

Group type: EXPERIMENTAL
Intervention: Bupivacaine 0.2% with fentanyl 2 microg mL(‐1)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Ropivacaine 0.2% with fentanyl 2 microg mL(‐1)
Number of subjects: 60
Study: 10189118

Group type: EXPERIMENTAL
Intervention: Sequence technique for evaluating baroreflex sensitivity (BRS)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Cross-spectral technique for evaluating baroreflex sensitivity (BRS)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Sequence technique (activating sequence)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Sequence technique (deactivating sequence)
Number of subjects: 0
Study: 7598090

Group type: EXPERIMENTAL
Intervention: 30‐minute sports massage of the lower extremities
Number of subjects: 10

Group type: COMPARATOR
Intervention: Control Session (motionless for 30 minutes)
Number of subjects: 10
Study: 2240994

Group type: EXPERIMENTAL
Intervention: Trimetazidine (60 mg/day)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Betahistine (24 mg/day)
Number of subjects: 36
Study: 7372228

Group type: EXPERIMENTAL
Intervention: 0.5 mg digoxin b.i.d.
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: 0.25 mg digoxin b.i.d.
Number of subjects: 23

Group type: COMPARATOR
Intervention: 0.2 mg beta-methyl-digoxin b.i.d.
Number of subjects: 23
Study: 6386561

Group type: EXPERIMENTAL
Intervention: Protocol A (NST, OCT, serum unconjugated estriol measurements, ultrasound measurement of H/A c.r.)
Number of subjects: 306

Group type: COMPARATOR
Intervention: Protocol B (NST, OCT, ultrasound measurement of H/A)
Number of subjects: 306

Group type: EXPERIMENTAL
Intervention: Protocol A
Number of subjects: 306

Group type: EXPERIMENTAL
Intervention: Serum free estriol measurements
Number of subjects: 306

Group type: EXPERIMENTAL
Intervention: Hypertensive pregnancy management without serum free estriol measurement
Number of subjects: 306
Study: 30507228

Group type: EXPERIMENTAL
Intervention: Attention Bias Modification (ABM)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Sham Control
Number of subjects: 70